IRCT20111206008307N37招募中1 期
The impact of Triamterene-Hydrochlorothiazide plus Furosemide versus Hydrochlorothiazide plus Furosemide in patients with heart failure and Refractory edema: A randomized clinical trial.
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Patients with systolic and diastolic heart failure and refractory edema
排除标准
- •Renal dysfunctin (creatinine clearance of <30 ml/min)
- •History of end-stage renal failure or dialysis
- •Cardiogenic shock
- •Acute myocardial infarction
- •Hypoalbuminemia
- •Any contraindications for Triamterene-Hydrochlorothiazide and Hydrochlorothiazide
- •Patients who are not satisfied
研究者
相似试验
已完成
3 期
The effect of tamsulosin and hydrochlorothiazide on stone excretioIRCT20200704047998N1Iran University of Medical Sciences240
招募中
Unknown
In vivo Bioequivalence study of Hydrochlorothiazide tabletIRCT20220211053992N21Tabriz University of Medical Sciences24
进行中（未招募）
不适用
Efficacy and Safety of Hydrochlorothiazide Used as Add-on Therapy in Moderately to Severely Hypertensive Patients not Adequately Controlled by Olmesartan Medoxomil 40 mg MonotherapyEssential hypertensionMedDRA version: 8.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2006-003876-37-CZDAIICHI SANKYO EUROPE GmbH2,220
进行中（未招募）
1 期
Efficacy and Safety of Hydrochlorothiazide Used as Add-on Therapy in Moderately to Severely Hypertensive Patients not Adequately Controlled by Olmesartan Medoxomil 40 mg MonotherapyEficacia y seguridad de Hidroclorotiazida, utilizada como terapia adicional, en pacientes con hipertensión moderada a severa no controlados adecuadamente con Olmesartan MEdoxomil 40 mg en monoterapiaEssential hypertensionHipertensión esencialMedDRA version: 8.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2006-003876-37-ESDAIICHI SANKYO EUROPE GmbH1,500
进行中（未招募）
不适用
Efficacy and Safety of Hydrochlorothiazide Used as Add-on Therapy in Moderately to Severely Hypertensive Patients not Adequately Controlled by Olmesartan Medoxomil 40 mg MonotherapyEssential hypertensionMedDRA version: 8.1Level: LLTClassification code 10015488Term: Essential hypertensionEUCTR2006-003876-37-DEDAIICHI SANKYO EUROPE GmbH1,500